Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies

BACKGROUND: The ability of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to decrease certain microvascular events has called for the investigation of GLP-1 RAs against diabetic retinopathy (DR), but the evidence is limited. By combining data from observational and Mendelian randomization (MR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Deqiang, Li, Ning, Hou, Rui, Zhang, Xiaoyu, Wu, Lijuan, Sundquist, Jan, Sundquist, Kristina, Ji, Jianguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898966/
https://www.ncbi.nlm.nih.gov/pubmed/36737746
http://dx.doi.org/10.1186/s12916-023-02753-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898966/
https://www.ncbi.nlm.nih.gov/pubmed/36737746
http://dx.doi.org/10.1186/s12916-023-02753-6

Ejemplares similares